KYORIN Holdings, Inc. (4569.T)
JPY 1440.0
(-0.89%)
JPY 1440.0
(-0.89%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 46.89 Billion JPY | -7.3% |
| 2022 | 50.58 Billion JPY | 6.68% |
| 2021 | 47.41 Billion JPY | 11.66% |
| 2020 | 42.46 Billion JPY | -12.35% |
| 2019 | 48.45 Billion JPY | -2.4% |
| 2018 | 49.63 Billion JPY | 41.61% |
| 2017 | 35.05 Billion JPY | 0.64% |
| 2016 | 34.83 Billion JPY | -14.58% |
| 2015 | 40.77 Billion JPY | 17.23% |
| 2014 | 34.78 Billion JPY | 10.22% |
| 2013 | 31.55 Billion JPY | 21.99% |
| 2012 | 25.87 Billion JPY | -5.83% |
| 2011 | 27.47 Billion JPY | -22.68% |
| 2010 | 35.52 Billion JPY | 10.07% |
| 2009 | 32.27 Billion JPY | 15.07% |
| 2008 | 28.05 Billion JPY | 11.25% |
| 2007 | 25.21 Billion JPY | -2.5% |
| 2006 | 25.86 Billion JPY | 0.72% |
| 2005 | 25.67 Billion JPY | 37.38% |
| 2004 | 18.69 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 49.86 Billion JPY | 6.34% |
| 2023 Q2 | 49.94 Billion JPY | 4.52% |
| 2023 Q3 | 52.36 Billion JPY | 4.83% |
| 2023 FY | 46.89 Billion JPY | -7.3% |
| 2023 Q1 | 47.79 Billion JPY | -5.53% |
| 2023 Q4 | 46.89 Billion JPY | -10.45% |
| 2022 Q1 | 45.98 Billion JPY | -3.01% |
| 2022 Q3 | 47.77 Billion JPY | -5.82% |
| 2022 FY | 50.58 Billion JPY | 6.68% |
| 2022 Q2 | 50.72 Billion JPY | 10.3% |
| 2022 Q4 | 50.58 Billion JPY | 5.88% |
| 2021 Q4 | 47.41 Billion JPY | 2.51% |
| 2021 Q1 | 42.47 Billion JPY | 0.02% |
| 2021 Q2 | 42.48 Billion JPY | 0.01% |
| 2021 Q3 | 46.25 Billion JPY | 8.88% |
| 2021 FY | 47.41 Billion JPY | 11.66% |
| 2020 FY | 42.46 Billion JPY | -12.35% |
| 2020 Q3 | 46.28 Billion JPY | -0.22% |
| 2020 Q4 | 42.46 Billion JPY | -8.25% |
| 2020 Q1 | 45.5 Billion JPY | -6.08% |
| 2020 Q2 | 46.38 Billion JPY | 1.94% |
| 2019 FY | 48.45 Billion JPY | -2.4% |
| 2019 Q1 | 48.12 Billion JPY | -3.05% |
| 2019 Q4 | 48.45 Billion JPY | -2.97% |
| 2019 Q2 | 46.38 Billion JPY | -3.63% |
| 2019 Q3 | 49.93 Billion JPY | 7.66% |
| 2018 Q2 | 31.63 Billion JPY | 0.77% |
| 2018 Q4 | 49.63 Billion JPY | -3.05% |
| 2018 FY | 49.63 Billion JPY | 41.61% |
| 2018 Q1 | 31.39 Billion JPY | -10.44% |
| 2018 Q3 | 51.19 Billion JPY | 61.82% |
| 2017 Q3 | 33.19 Billion JPY | 2.16% |
| 2017 FY | 35.05 Billion JPY | 0.64% |
| 2017 Q4 | 35.05 Billion JPY | 5.6% |
| 2017 Q2 | 32.49 Billion JPY | -2.65% |
| 2017 Q1 | 33.37 Billion JPY | -4.18% |
| 2016 Q4 | 34.83 Billion JPY | -5.94% |
| 2016 Q3 | 37.03 Billion JPY | 7.14% |
| 2016 Q1 | 38.87 Billion JPY | -4.67% |
| 2016 FY | 34.83 Billion JPY | -14.58% |
| 2016 Q2 | 34.56 Billion JPY | -11.07% |
| 2015 Q3 | 37.07 Billion JPY | 2.74% |
| 2015 Q4 | 40.77 Billion JPY | 9.99% |
| 2015 FY | 40.77 Billion JPY | 17.23% |
| 2015 Q1 | 36.94 Billion JPY | 6.2% |
| 2015 Q2 | 36.08 Billion JPY | -2.32% |
| 2014 Q4 | 34.78 Billion JPY | 15.19% |
| 2014 Q3 | 30.19 Billion JPY | 19.28% |
| 2014 Q1 | 29.46 Billion JPY | -6.62% |
| 2014 Q2 | 25.31 Billion JPY | -14.09% |
| 2014 FY | 34.78 Billion JPY | 10.22% |
| 2013 Q2 | 25.74 Billion JPY | -11.61% |
| 2013 Q1 | 29.12 Billion JPY | 12.58% |
| 2013 FY | 31.55 Billion JPY | 21.99% |
| 2013 Q4 | 31.55 Billion JPY | 25.36% |
| 2013 Q3 | 25.17 Billion JPY | -2.21% |
| 2012 Q3 | 28.31 Billion JPY | 4.02% |
| 2012 Q2 | 27.22 Billion JPY | -7.59% |
| 2012 Q1 | 29.46 Billion JPY | 7.24% |
| 2012 FY | 25.87 Billion JPY | -5.83% |
| 2012 Q4 | 25.87 Billion JPY | -8.65% |
| 2011 FY | 27.47 Billion JPY | -22.68% |
| 2011 Q3 | 26.8 Billion JPY | 4.21% |
| 2011 Q2 | 25.72 Billion JPY | -23.11% |
| 2011 Q1 | 33.45 Billion JPY | -5.84% |
| 2011 Q4 | 27.47 Billion JPY | 2.48% |
| 2010 Q2 | 23.87 Billion JPY | -17.65% |
| 2010 FY | 35.52 Billion JPY | 10.07% |
| 2010 Q1 | 28.99 Billion JPY | -10.17% |
| 2010 Q3 | 34.06 Billion JPY | 42.64% |
| 2010 Q4 | 35.52 Billion JPY | 4.31% |
| 2009 Q4 | 32.27 Billion JPY | 5.79% |
| 2009 Q3 | 30.51 Billion JPY | 10.13% |
| 2009 FY | 32.27 Billion JPY | 15.07% |
| 2009 Q2 | 27.7 Billion JPY | 0.0% |
| 2008 Q4 | 28.05 Billion JPY | -8.27% |
| 2008 FY | 28.05 Billion JPY | 11.25% |
| 2008 Q3 | 30.58 Billion JPY | 0.0% |
| 2007 FY | 25.21 Billion JPY | -2.5% |
| 2006 FY | 25.86 Billion JPY | 0.72% |
| 2005 FY | 25.67 Billion JPY | 37.38% |
| 2004 FY | 18.69 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -87.662% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.401% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 93.759% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 71.468% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -1281.246% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | -9.389% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -68.28% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 90.523% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -830.417% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 23.991% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -52.092% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | -17.839% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | -50.859% |
| Tsumura & Co. | 132.88 Billion JPY | 64.712% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | -17.848% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -252.658% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 82.933% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | -6.194% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 33.678% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -569.613% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -84.335% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -475.93% |
| MedRx Co., Ltd | 129 Million JPY | -36251.163% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -1332.926% |
| Solasia Pharma K.K. | 673 Million JPY | -6867.756% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -7164.567% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | -49.431% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 71.406% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -4536.72% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 91.051% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -574.492% |